Page 3 of zydus

Jefferies sees 2% downside potential for Zydus; puts ‘Hold’ rating with target price of Rs 630

Zydus Lifesciences holds a dominant position in the production of Asacol HD and is the leading player in the Mesalamine…

September 21, 2023 13:19 IST

Goldman Sachs, India Inc, midcap companies, overseas investors, capitalization, foreign inflow

Zydus Lifesciences Q1 profit surges to Rs 1086.90 crore, revenue up 29.6% on US sales growth

Zydus Lifesciences posted revenue from operations at Rs 5139.60 crore, up 29.6 per cent in comparison to Rs 3964.30 crore…

August 11, 2023 13:15 IST

healthcare revolution, health news, pharma news,

USFDA gives final nod to Zydus’ tablets for treatment of seizures

Oxcarbazepine Tablets USP, 150 mg, 300 mg and 600 mg had annual sales of USD 105 mn in the United…

July 4, 2023 13:47 IST

Zydus Lifesciences, Zydus Lifesciences q4, Zydus Lifesciences profit,

Zydus Lifesciences Q4 consolidated net profit dips 25.36 pc to Rs 296.6 cr

Consolidated total revenue from operations stood at Rs 5,010.6 crore, as against Rs 3,805.6 crore in the corresponding period a…

May 18, 2023 18:47 IST

Zydus Wellness, Zydus Wellness Q2 results, profit, revenue, EBITDA, key brands, personal care segment, digital engagement

Zydus Wellness Q4 net profit rise to Rs 145 crore

The company had posted a consolidated net profit of Rs 133.3 crore in the year-ago period, Zydus Wellness said in…

Updated: May 17, 2023 15:16 IST

GlobalData, Rare Diseases, China market, healthcare news, pharma news,

USFDA tentatively approves Zydus’ tablets for seizures treatment

According to data by IQVIA MAT in December 2022, Gabapentin Tablets had annual sales of USD 90 million in the…

February 21, 2023 14:20 IST

Breast cancer, breast cancer awareness, breast cancer treatment, healthcare news,

Zydus Lifesciences gets exclusive marketing rights for OncoStem’s prognostic test for breast cancer

Breast cancer is the leading cause of cancer in women in India and its risk increases with age. It is…

November 16, 2022 15:07 IST

Zydus Lifesciences, Zydus Lifesciences net profit, Zydus Lifesciences growth

Zydus Lifesciences net profit plunge by 82.6%

The company’s Research & Development (R&D) investments for the quarter stood at Rs 253 crore which is 6.1% of revenues.

Updated: November 13, 2022 18:58 IST

Practo, Practo corporates, Practo Cashless OPD, Practo india, healthcare news, healthtech news,

USFDA approves 2 generic drugs of Zydus Lifesciences

According to the company, both drugs will be manufactured at the group’s formulation manufacturing facility in Ahmedabad SEZ.

October 17, 2022 14:21 IST

cfo, hdfc, standard chartered, zydus, peppyfry, puma

Keki Mistry, Jaspal Bindra, other industry A-listers to share insights at the FE CFO Connect Conclave

The FE CFO Connect Conclave 2022 is seeing some of the best minds from the Indian financial world and the…

September 18, 2022 10:27 IST

The Gujarat-based firm had posted a net profit of Rs 597 crore in the April-June quarter of the last fiscal.

Zydus Lifesciences Q1 consolidated net profit falls to Rs 518 crore

However, excluding sales of COVID related products, the business grew 12 per cent year-on-year.

August 10, 2022 17:27 IST

Zydus gets USFDA nod for chemotherapy drug

The approval granted by the US Food and Drug Administration (USFDA) is for Pemetrexed for injection, in strengths of 100…

May 26, 2022 15:32 IST

Zydus Lifesciences gets USFDA nod for generic product

The approval granted by the US Food and Drug Administration (USFDA) is for Cyanocobalamin injection in strengths of 1,000 mcg/ml,…

April 18, 2022 15:29 IST

FE Pharma Summit, Sun Pharmaceutical, Zydus Cadila, Glenmark Pharmaceuticals, Biocon, DCGI

FE Pharma Summit to see industry titans swap ideas on steps to counter prickly challenges

The two day FE Pharma Summit 2022 is also an attempt to leverage the ability of the Indian pharma stakeholders…

Updated: March 23, 2022 15:05 IST

Zydus Lifesciences gets USFDA nod to market generic version of colestipol hydrochloride tablets

The approval by the US Food and Drug Administration is for colestipol hydrochloride of 1 mg strength, the company said…

Updated: March 14, 2022 12:31 IST

Zydus gets DCGI nod for drug to treat anaemia associated with chronic kidney disease

The clinical development programme of Desidustat was one of the largest trials of its kind in India for Anemia in…

March 7, 2022 13:11 IST

Cadila Healthcare, Zydus Lifesciences, malaria, biologics, vaccines, Plasmid DNA Vaccine, ZyCoV-D

Cadila Healthcare to be known as Zydus Lifesciences as part of new innovation centric corporate brand identity

The company’s new brand identity brings together two hearts in purple and teal colours symbolising its commitment to science and…

February 25, 2022 13:37 IST

Related News

SC acts on viral timber log videos in Himachal, sparks political storm

SC takes suo motu cognisance of viral timber log videos, issues notices to Centre, state govts

Govt extended ITR AY 2025-26 deadline, but only 4.56 crore returns filed so far

China exits Pakistan’s $60 billion CPEC flagship project; Islamabad turns to ADB for funding

China exits Pakistan’s $60 billion economic corridor project; Islamabad turns to ADB for funding

Who is the new James Bond? 007 First Light introduces a new face to the screen; all details inside

RBI's CRR Cut to Infuse ₹60,000 Crore, Boosting Banking System Liquidity. (Image Source: Reuters)

First 25-bps CRR cut takes effect today

Alakh Pandey-led PhysicsWallah to raise Rs 3,820 cr via IPO, files updated papers

Market5 min ago

PhysicsWallah, a leading edtech company, plans to raise Rs 3,820 crore through an IPO. The proposed IPO includes a fresh issue of equity shares and an offer for sale by promoters. The funds will be used for expansion, growth, and investments in subsidiary and offline centers. Backed by top investors, including WestBridge Capital and GSV.

View all shorts